Get started
Author

Douglas J. Haney

Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor
2016 · Wilbur H. Chen, Mitchell B. Cohen, et al. · Clinical Infectious Diseases · 192
Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
2012 · Jeffrey R. Curtis, Annette H. van der Helm‐van Mil, et al. · Arthritis Care & Research · 190
PDF
Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis
2013 · Michael Centola, Guy Cavet, et al. · PLoS ONE · 188
PDF
Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis*
2010 · Michiel E. Stegenga, Jean-Louis Vincent, et al. · Critical Care Medicine · 137
Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study
2012 · Marije F Bakker, Guy Cavet, et al. · Annals of the Rheumatic Diseases · 122
PDF
Dynamics of CD4 and CD8 T Cell Responses to Cytomegalovirus in Healthy Human Donors
2002 · Holli S. Dunn, Douglas J. Haney, et al. · The Journal of Infectious Diseases · 116
Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies
1995 · Martha K. Terris, Douglas J. Haney, et al. · Urology · 110
Kidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease
2007 · Katherine R. Tuttle, Janet B. McGill, et al. · Clinical Journal of the American Society of Nephrology · 94
Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis
2012 · P. Scott Eastman, William C. Manning, et al. · Journal of Pharmaceutical and Biomedical Analysis · 86
PDF
An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression
2013 · Annette H. M. van der Helm-van Mil, Rachel Knevel, et al. · Rheumatology · 68
ENHANCE: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis*
2006 · Brahm Goldstein, Simon Nadel, et al. · Pediatric Critical Care Medicine · 61
Effect of Ruboxistaurin on Urinary Transforming Growth Factor-β in Patients With Diabetic Nephropathy and Type 2 Diabetes
2007 · Richard E. Gilbert, Sandra A. Kim, et al. · Diabetes Care · 53
Biomarkers of Thrombosis, Fibrinolysis, and Inflammation in Patients with Severe Sepsis due to Community-Acquired Pneumonia with and without Streptococcus pneumoniae
2009 · G. M. Vail, Y. J. Xie, et al. · Infection · 35
Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers
2018 · Kamrul Islam, Motaher Hossain, et al. · PLoS neglected tropical diseases · 32
PDF
Antibody-Based Correlates of Protection against Cholera: Analysis of a Challenge Study of a Cholera-Naive Population
2017 · Douglas J. Haney, Michael D. Lock, et al. · Clinical and Vaccine Immunology · 31
Severe protein C deficiency is associated with organ dysfunction in patients with severe sepsis
2011 · Andrew D. Shaw, George M. Vail, et al. · Journal of Critical Care · 31
Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection
2018 · Douglas J. Haney, Michael D. Lock, et al. · Vaccine · 24
PDF
The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae
2016 · Leslie M. Mayo-Smith, Jakub K. Simon, et al. · Clinical and Vaccine Immunology · 18
Update on CVD 103-HgR single-dose, live oral cholera vaccine
2021 · James McCarty, Lisa Bedell, et al. · Expert Review of Vaccines · 16
FRI0061 Multi-biomarker disease activity (MBDA) score and the 12 individual biomarkers in early rheumatoid arthritis patients relate differentially to clinical response and radiographic progression: results from the swefot trial
2013 · K. Hambardzumyan, S. Saevarsdottir, et al. · Annals of the Rheumatic Diseases · 4
FRI0060 A multi-biomarker disease activity blood test (vectra da) correlates with radiographic progression in early rheumatoid arthritis: results from the swefot trial
2013 · K. Hambardzumyan, R. Bolce, et al. · Annals of the Rheumatic Diseases · 3
Prostate specific antigen as a predictor of an abnormal digital rectal examination
1994 · P.D. LUI, M.K. TERRIS, et al. · British Journal of Urology · 3
SAT0099 Application of a Multi-Biomarker Disease Activity (VECTRA™ TA) Score for Assessing Rheumatoid Arthritis Patients with Low Crp or Fibromyalgia
2013 · Y.C. Lee, D. Haney, et al. · Annals of the Rheumatic Diseases · 2
FRI0079 Response to mtx plus prednisone in camera ii using a multi-biomarker disease activity test (vectra™ da) and das28-esr
2013 · M.S. Jurgens, J.W. Bijlsma, et al. · Annals of the Rheumatic Diseases · 2
FRI0098 Biomarker-based estimates of risk of radiographic progression in the leiden early arthritis cohort
2013 · W. Li, A. van der Helm-van Mil, et al. · Annals of the Rheumatic Diseases · 2
Works count: 35
Citation count: 1,623
H-index: 18
I10-index: 19
Year
Topic
Type